Roberts Glore & CO Inc Medpace Holdings, Inc. Transaction History

Roberts Glore & CO Inc

$328 Million
Q4 2024

A detailed history of Roberts Glore & CO Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Roberts Glore & CO Inc holds 4,161 shares of MEDP stock, worth $1.37 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

4,161

Previous 4,081 1.96%

Holding current value

$1.37 Million

Previous $1.36 Million 1.62%

% of portfolio

0.42%

Previous 0.4%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$308.93 - $363.58 $24,714 - $29,086	80 Added 1.96%	4,161 $1.38 Million
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $8,014 - $11,432	-25 Reduced 0.61%	4,081 $1.36 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $244,032 - $278,367	-656 Reduced 13.78%	4,106 $1.69 Million
Q1 2024 May 09, 2024	SELL	$284.87 - $413.31 $190,293 - $276,091	-668 Reduced 12.3%	4,762 $1.92 Million
Q4 2023 Feb 12, 2024	SELL	$227.52 - $312.68 $96,013 - $131,950	-422 Reduced 7.21%	5,430 $1.66 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $8,426 - $10,807	45 Added 0.77%	5,852 $1.41 Million
Q1 2023 May 08, 2023	SELL	$174.31 - $239.52 $14,816 - $20,359	-85 Reduced 1.44%	5,807 $1.09 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $67,499 - $99,917	-441 Reduced 6.96%	5,892 $1.25 Million
Q3 2022 Nov 07, 2022	SELL	$145.13 - $182.49 $5,805 - $7,299	-40 Reduced 0.63%	6,333 $995,000
Q2 2022 Aug 11, 2022	BUY	$130.2 - $168.03 $534,210 - $689,427	4,103 Added 180.75%	6,373 $954,000
Q1 2022 May 02, 2022	BUY	$138.87 - $214.31 $315,234 - $486,483	2,270 New	2,270 $371,000

Others Institutions Holding MEDP

# of Institutions

625

Shares Held

25.7M

Call Options Held

74.3K

Put Options Held

79.1K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.2B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account

Roberts Glore & CO Inc Medpace Holdings, Inc. Transaction History